NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared Luminex's xTAG Gastrointestinal Pathogen Panel for marketing in the US, Luminex announced today.

The assay is cleared to run on the Luminex 100/200 system, and Luminex said that it is "the first comprehensive molecular diagnostic assay that tests more than 90 percent of bacterial, viral, and parasitic causes of infectious gastroenteritis in a single assay."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.